Our Story

TrialIO is the brainchild of Ron Ranauro, an experienced software entrepreneur and computer scientist.
After experiencing the pain of wrangling spreadsheets at ClinicalTrials.gov on behalf of a consulting client, he decided there had to be a better way.  In 2015 Ron and a small team of developers set out to create the TrialIO platform so that non-programmers could easily mine and interact with clinical trial data.

 
  Founder and CEO

Founder and CEO

Ron Ranauro

In 2010 Ron founded Incite Advisors, a venture studio with a mission to create software businesses addressing unmet needs in healthcare and life science. TrialIO was born of that effort. Previously in 2002 he joined GenomeQuest (formerly Gene-IT, SA) and in 2005 he organized a venture financing and was was appointed CEO. GenomeQuest created one of the first profitable bioinformatics subscription businesses. In 1996 he founded Blackstone Technology Group where he built a successful life science consulting practice. Previously he held software engineering, marketing, and business development roles at Viewlogic and Exemplar Logic in the Electronics Design Automation field. Ron holds a BS Management Engineering and an MS Computer Science both from Worcester Polytechnic Institute.

 
 
  Advisor

Advisor

Romiya Glover Barry

Romiya Glover Barry is a clinical research professional in the medical device field where she leverages her experience in product development, clinical marketing, trial operations, and regulatory affairs. She has provided oversight to several international, multi-center, observational and comparative studies. Her research collaborations focus on the investigation and design of solutions to enhance the quality of clinical program management. Additionally, she volunteers with several organizations focused on research translation initiatives. Ms. Barry has a BS in Biology & Biotechnology from Worcester Polytechnic Institute, an MS in Clinical Investigation from the Massachusetts General Hospital Institute of Health Professions, and doctoral training as a translational health scientist from The George Washington University.